US Patent
US8642075 — Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
Formulation · Assigned to Insmed Inc · Expires 2026-12-05 · 1y remaining
Vulnerability score
60/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects a system for treating or preventing pulmonary infections using a pharmaceutical formulation of an antiinfective, such as amikacin sulfate, in a lipid-based composition.
USPTO Abstract
A system for treating or providing prophylaxis against a pulmonary infection is disclosed comprising: a) a pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition, and b) an inhalation delivery device. A method for providing prophylaxis against a pulmonary infection in a patient and a method of reducing the loss of antiinfective encapsulated in a lipid-based composition upon nebulization comprising administering an aerosolized pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition is also disclosed.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.